SEC Form 4 · accession 0001179110-17-008550
Axogen, Inc. · AXGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert James Rudelius
Director
Period of report
Jun 1, 2017
Accepted (ET)
Jun 5, 2017 · 4:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000805928
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to purchase)F1 | $14.85 | Jun 1, 2017 | A | 15,000 | A | — | Jun 1, 2027 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1Non-qualified stock option grant for service as Director on Company's Board of directors. Options vest in equal installments every three months for the first nine months, with the final installment vesting on the date of the then current annual meeting.